Bayer HealthCare Pharmaceuticals

Hematology / Cardiology
Bayer HealthCare Pharmaceuticals is among the top five specialty pharmaceutical companies in Canada and is a leader in the field of hematology and cardiology. For more than 20 years, Bayer HealthCare Pharmaceuticals, together with its international affiliates, has been extending and enhancing the lives of patients with chronic blood coagulation disorders such as hemophilia through the development of innovative and safe treatment options.

Although hemophilia remains incurable to this day, Bayer is one of the world’s main suppliers of products to treat this hereditary disease. We recognize the great medical need for therapies that can improve the quality of life. Our focus of research in hemophilia is to develop a novel therapy that lasts longer in the body in such a way that it need not be injected so frequently.

We are deeply committed to providing Canadians with the best medicine and continue to invest in the research and development of innovative pharmaceutical products to improve the lives of patients.

For more information on Bayer HealthCare Pharmaceuticals and its commitment to hematology and cardiology, please visit our Web site. - Bayer